首页 | 本学科首页   官方微博 | 高级检索  
     


Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective
Authors:Werner A Scherbaum  Gordon Goodall  Katrina M Erny-Albrecht  Massimo Massi-Benedetti  Erland Erdmann  William J Valentine
Affiliation:1. National Malaria Control Centre, Box 32509, Lusaka, Zambia
2. Health Economics Unit, Department of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa
3. Department of Economics, University of Zambia, Lusaka, Zambia
Abstract:
Keywords:
本文献已被 SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号